JP2012531205A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531205A5
JP2012531205A5 JP2012517731A JP2012517731A JP2012531205A5 JP 2012531205 A5 JP2012531205 A5 JP 2012531205A5 JP 2012517731 A JP2012517731 A JP 2012517731A JP 2012517731 A JP2012517731 A JP 2012517731A JP 2012531205 A5 JP2012531205 A5 JP 2012531205A5
Authority
JP
Japan
Prior art keywords
influenza virus
polypeptide
recombinant
amino acid
reassortant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012517731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531205A (ja
JP5745511B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/039826 external-priority patent/WO2010151673A1/en
Publication of JP2012531205A publication Critical patent/JP2012531205A/ja
Publication of JP2012531205A5 publication Critical patent/JP2012531205A5/ja
Application granted granted Critical
Publication of JP5745511B2 publication Critical patent/JP5745511B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012517731A 2009-06-25 2010-06-24 ブタインフルエンザヘマグルチニン変異体 Expired - Fee Related JP5745511B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US22042609P 2009-06-25 2009-06-25
US61/220,426 2009-06-25
US22798609P 2009-07-23 2009-07-23
US61/227,986 2009-07-23
US23402109P 2009-08-14 2009-08-14
US61/234,021 2009-08-14
US25889009P 2009-11-06 2009-11-06
US61/258,890 2009-11-06
PCT/US2010/039826 WO2010151673A1 (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants

Publications (3)

Publication Number Publication Date
JP2012531205A JP2012531205A (ja) 2012-12-10
JP2012531205A5 true JP2012531205A5 (enExample) 2013-06-13
JP5745511B2 JP5745511B2 (ja) 2015-07-08

Family

ID=43386887

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517731A Expired - Fee Related JP5745511B2 (ja) 2009-06-25 2010-06-24 ブタインフルエンザヘマグルチニン変異体

Country Status (13)

Country Link
US (2) US8088393B2 (enExample)
EP (1) EP2448598B1 (enExample)
JP (1) JP5745511B2 (enExample)
KR (1) KR20120101318A (enExample)
CN (1) CN102802666B (enExample)
AU (2) AU2010266078B2 (enExample)
BR (1) BRPI1014844A2 (enExample)
CA (1) CA2766377A1 (enExample)
MX (1) MX2012000123A (enExample)
NZ (2) NZ596823A (enExample)
RU (1) RU2560420C2 (enExample)
SG (2) SG176178A1 (enExample)
WO (1) WO2010151673A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010151673A1 (en) 2009-06-25 2010-12-29 Medimmune, Llc Swine influenza hemagglutinin variants
JP2015501141A (ja) * 2011-10-07 2015-01-15 メディミューン,エルエルシー インフルエンザヘマグルチニン変異体
KR101315273B1 (ko) * 2012-10-29 2013-10-08 대한민국 강독화된 인플루엔자 바이러스 변이주
EP2925356A2 (en) * 2012-12-03 2015-10-07 Novartis AG Reassortant influenza a viren
SG11201609207SA (en) * 2014-05-13 2016-12-29 Univ Pennsylvania Compositions comprising aav expressing dual antibody constructs and uses thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN108135994B (zh) 2015-05-13 2022-01-25 宾夕法尼亚州大学信托人 Aav-介导的抗-流感抗体的表达及其使用方法
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
US11827906B2 (en) 2017-02-28 2023-11-28 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clade f vector and uses therefor
SG11201907611WA (en) 2017-02-28 2019-09-27 Univ Pennsylvania Influenza vaccines based on aav vectors
RU2020124143A (ru) 2017-12-22 2022-01-24 Кодадженикс Инк. Рекомбинантный вирус с областью деоптимизированной пары кодонов и его применение для лечения рака
BR112020018188A2 (pt) 2018-03-08 2021-02-02 Codagenix Inc. flavivírus atenuados
WO2025081053A1 (en) * 2023-10-11 2025-04-17 Flugen, Inc. Formulations for thermostable vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
EP1945778B1 (en) * 2005-10-17 2012-12-26 MedImmune, LLC Methods of increasing influenza virus replication
JP2010500034A (ja) * 2006-08-09 2010-01-07 メッドイミューン バクシーンズ,インコーポレイティド インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
WO2008145129A2 (en) 2007-05-31 2008-12-04 Statens Serum Institut Influenza vaccines
WO2010151673A1 (en) 2009-06-25 2010-12-29 Medimmune, Llc Swine influenza hemagglutinin variants

Similar Documents

Publication Publication Date Title
JP2012531205A5 (enExample)
RU2012102385A (ru) Варианты гемагглютининов вируса свиного гриппа
Begum et al. Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development
KR100632429B1 (ko) 프라이머 특이성 유무에 의한 멀티플렉스 역전사 중합효소연쇄반응을 이용한 재조합 독감 바이러스의 스크리닝 방법
Yang et al. Human infection from avian-like influenza A (H1N1) viruses in pigs, China
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
Tewawong et al. Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014
Evseev et al. Molecular evolution of the influenza A virus non-structural protein 1 in interspecies transmission and adaptation
Jang et al. Principles underlying rational design of live attenuated influenza vaccines
Le Gall-Recule et al. Double introduction of highly pathogenic H5N1 avian influenza virus into France in early 2006
Bashashati et al. Genetic diversity of early (1998) and recent (2010) avian influenza H9N2 virus strains isolated from poultry in Iran
JP2008522621A (ja) 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン
Rash et al. An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA-X protein
Fang et al. Molecular epidemiology and evolution of A (H1N1) pdm09 and H3N2 virus during winter 2012–2013 in Beijing, China
Pohuang et al. Sequence analysis of S1 genes of infectious bronchitis virus isolated in Thailand during 2008–2009: identification of natural recombination in the field isolates
Swati et al. Isolation and phylogenetic characterization of Canine distemper virus from India
Looi et al. How far have we reached in development of effective influenza vaccine?
EP2716752A1 (en) Canine influenza recombinant virus, preparation method therefor and application thereof
Mameli et al. Influenza vaccine response: future perspectives
RU2011137404A (ru) Варианты гемагглютинина и нейраминидазы гриппа
CN102600466B (zh) 抗甲型流感病毒新型通用表位疫苗及其制备方法
JP2012517239A5 (enExample)
Zhou et al. One HA stalk topping multiple heads as a novel influenza vaccine
Hong et al. Comparative genomics of QX-like infectious bronchitis viruses in Korea
Hosseini et al. Phylogenetic analysis of H9N2 avian influenza viruses in Afghanistan (2016-2017)